
While cellular senescence and immunosenescence jointly drive organismal aging, how these two processes interact remains a critical knowledge gap. Here, senescence-associated beta-galactosidase (SA-ß-gal) activity is used to identify a senescence-associated phenotype across major lymphocyte lineages. We examined its overlap with terminal differentiation markers during human aging and explored its association with clinical correlates. Peripheral blood mononuclear cells from 208 Cuban individuals aged 20–104 years were analyzed by spectral flow cytometry. SA-β-galhigh lymphocytes exhibited multiple hallmarks of cellular senescence, including increased expression of cell-cycle inhibitors, DNA damage, mitochondrial oxidative stress, and increased production of pro-inflammatory cytokines. Across T, B, and NK cell compartments, SA-β-gal activity was enriched in highly differentiated populations, including CD4 + and CD8 + EMRA T cells, double-negative B cells, and mature cytotoxic NK cells. However, SA-β-galhigh cells were also detected in less differentiated subsets. Aging was associated with a progressive increase of the SA-β-gal signature across major lymphocyte lineage, driven by both the expansion of differentiated subpopulations and increase in the frequency of SA-β-galhigh cells within subsets among all stages of differentiation. Structural equation modeling revealed associations between senescence-associated immune phenotypes with cognitive decline, reduced functionality, and lower physical robustness in the elderly. Notably, DN B cell SA-β-gal burden remained associated with physical robustness after adjustment for chronological age. SA-β-gal activity accumulates across major lymphocyte lineages, while displaying distinct, lineage-specific kinetics across the lifespan. While traditional T cell aging markers primarily reflect chronological aging across the lifespan, SA-β-gal activity in DN B cells may capture inter-individual differences in physical robustness among older adults. These findings support the integration of senescence-associated immune phenotypes into multidimensional approaches to better distinguish biological from chronological aging.
Aging is associated with progressive changes in immune regulation, brain function, metabolic homeostasis, and physical performance, which in turn increases susceptibility to neurodegenerative disorders and diminishes quality of life. Emerging evidence indicates that the gut–brain–immune axis is a key biological interface through which lifestyle interventions may influence age-related physiological changes. Dance-based interventions—complex multisystem stimuli that integrate aerobic exercise, motor coordination, cognitive involvement, social engagement, and emotional expression—have attracted growing interest as potential components of healthy aging. This review examines the evidence for and candidate mechanisms linking dance-based exercise with the gut–brain–immune axis, immune homeostasis, neuroplasticity, and cognitive resilience. Particular attention is given to microbiome-related pathways, microbiota-derived metabolites, inflammatory and immune signaling, mitochondrial and redox regulation, and neural mechanisms relevant to cognitive and emotional function. We distinguish direct evidence from human dance interventions from evidence derived from broader exercise research and preclinical mechanistic studies, and evaluate their potential relevance to aging and neurodegenerative diseases. While existing evidence supports potential biological and functional benefits of dance-based interventions, direct evidence for dance-induced microbiome remodeling and its causal contribution to neuroimmune or cognitive outcomes remains limited. Thus, microbiome mediation of dance-associated neuroimmune and cognitive effects has not yet been established. Additional longitudinal, multi-omics, and mechanistically integrated studies are needed to clarify these relationships and determine whether gut–brain–immune pathways contribute to the effects of dance-based exercise during aging.
Aging is associated with heterogeneous cognitive outcomes, with some individuals maintaining cognitive resilience and others developing impairments. The gut microbiota modulates host immunity, inflammation, and brain function. However, its role in age-related cognitive heterogeneity remains unclear. In this study, we stratified aged rats into cognitively unimpaired (AU) and impaired (AI) groups using behavioral tests, including the attentional set-shifting task and Morris water maze. 16S rRNA gene sequencing of fecal samples revealed distinct gut microbial communities between the two groups, with AI rats exhibiting reduced diversity, elevated Firmicutes, and decreased Bacteroidetes. Through cross-group fecal microbiota transplantation, we demonstrated that gut microbiota played a causal role in shaping cognitive outcomes. AU recipients of AI microbiota developed cognitive deficits, whereas AI recipients of AU microbiota revealed improved flexibility and memory. To assess intestinal barrier integrity, serum LBP and I-FABP levels were measured as indirect markers of permeability. AU-derived microbiota decreased serum LBP and I-FABP levels, suggesting improved intestinal barrier function, whereas AI-derived microbiota did not significantly alter these markers. Flow cytometric analysis of peripheral blood mononuclear cells revealed reduced Treg and elevated Th1 and Th17 cells. Moreover, serum cytokine measurements revealed increased pro-inflammatory cytokine release in the AI group. These systemic alterations skewed microglial polarization toward a pro-inflammatory state in hippocampal tissues, thereby enhancing neuroinflammation and impairing cognition. Conversely, AU-derived microbiota restored Treg balance, increased anti-inflammatory cytokine levels, and inhibited microglial pro-inflammatory polarization, thereby protecting cognitive function. Our findings establish that gut microbiota modulate age-related cognitive heterogeneity through the gut-immune-brain axis, highlighting gut microbiota as a potential therapeutic target for age-related cognitive decline.
Aging is accompanied by progressive remodeling of the T cell compartment, yet the age-associated dynamics of the TCRβ repertoire, particularly across adulthood, and their sex-specific patterns remain incompletely understood. Here, we profiled the T-cell receptor β-chain (TCRβ) repertoires from 4,527 healthy individuals to characterize age-associated trajectories of the TCRβ repertoire. TCRβ repertoire diversity declines nonlinearly with age, with males exhibiting a pronounced contraction during early adulthood, while females display a more gradual decline. Despite these differences, both sexes display consistent shifts in V and J gene usage and preservation of stable public clonotypes. TCR convergence increases with age, which may reflect changes in T-cell subset composition and selective clonal expansion, consistent with age-associated immune remodeling of the TCRβ repertoire across adulthood. We next developed a TCRβ repertoire-based age prediction model, yielding a TCRβ-derived (predicted) age that showed a modest positive association with chronological age. Together, these findings delineate shared and sex-specific features of TCRβ repertoire remodeling across adulthood and provide a framework for further evaluating the relationship between TCRβ-derived age and independent measures of biological aging.
The disease burden of Atopic Dermatitis in the elderly is increasing in tandem with global population aging, and epidemiological studies have revealed a significantly elevated risk of cognitive impairment and Alzheimer’s disease associated with this condition,, posing a serious threat to their quality of life. However, the specific mechanisms by which skin inflammation mediates central nervous system (CNS) neurodegeneration across organs remain unclear. Cellular senescence and immunosenescence may form a positive feedback loop through Senescence-Associated Secretory Phenotype (SASP): senescent cells release SASP that induce chronic low-grade inflammation, while chronic inflammation in turn accelerates cellular senescence and immunosenescence, creating a vicious immune-aging cycle. From the perspective of the Immune-Aging Axis, this study demonstrates that skin-derived SASP drive the comorbidity mechanism of Atopic Dermatitis and Alzheimer’s disease in the elderly through bidirectional skin-brain feedback loops—including disruption of the blood-brain barrier, induction CNS inflammation, and epigenetic remodeling, with the aim of providing theoretical strategies for targeted combined interventions against SASP. 1. Innovative Integration of Theoretical Frameworks: This study innovatively applies the concept of the “Immuno-Aging Axis” to elucidate the context of comorbidity between Atopic Dermatitis and Alzheimer’s disease. 2. In-Depth Mechanistic Elucidation: By synthesizing existing literature, this review explores how SASP may mediate bidirectional interactions between the skin and CNS, providing a molecular bridge for interventions targeting this comorbidity. 3. Translational Clinical Value: This study provides a theoretical basis for targeting SASP to treat the comorbidity of Atopic Dermatitis and Alzheimer’s disease and advances the development of precision treatment strategies for elderly patients with comorbidities.